Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Health Retreat at Home: Taking care of oneself Practices - 2Becoming Familiar with an Unknown dialect: My Language Learning Excursion
- 3Partake in the Outside: Senior-Accommodating Exercises for 2024
- 4Best Streaming Gadget for Your Home Theater
- 5Compassion and Association: Building Significant Connections
- Former defense minister Gallant vacated home over security threat under Shin Bet direction
- CDC's upcoming vote on hepatitis B vaccine could impact childhood immunization
- The Tradition of Stone: A Gander at Notable Structures Through the Ages
- Magnetic fossils may reveal ancient creature's internal 'GPS system'
- NASA releases new photos of interstellar comet 3I/ATLAS
- 7 Fun Plans to Make Film Evenings Seriously Invigorating (You'll Cherish #5!)
- Uzbekistan launches €9.46 billion green energy push, covering nation’s power needs
- 25 of the world’s best sandwiches
- Extravagance SUVs for Seniors: Solace, Innovation, and Security
